Projects per year
Personal profile
Biography
Professor Stephen Kent trained as an infectious diseases physician and viral immunologist in Melbourne and the USA. He is a National Health and Medical Research Council Senior Principal Research Fellow. Stephen heads a lab studying immunity to HIV, Influenza, COVID-19 and other variable and difficult to vaccinate against viruses. Several vaccine concepts tested in his lab have shown sufficient promise to progress into human clinical trials. Stephen remains active in infectious diseases clinical medicine at the Alfred Hospital and Melbourne Sexual Health Centre. He is proud to lead a team of gifted scientists studying viral immunity. Links to his University blog and other details of his lab can also be found here.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
External positions
University of Melbourne
Research area keywords
- Viral infectious diseases
- HIV
- Influenza
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Bespoke nanomaterials for understanding nano-bio interactions under flow
Davis, T., Truong Phuoc, N., Kent, S. & Anastasaki, A.
1/01/20 → 23/11/23
Project: Research
-
Nano-Bioscience Imaging Facility
Caruso, F., Davis, T., Kent, S., Porter, C., Johnston, A., Qiao, G., Sexton, P., Crampin, E. J., Boyd, B., Cavalieri, F. & Hodgkin, P. D.
Project: Other
-
LCSRIF: Live Cell Super Resolution Imaging Facility
Caruso, F., Porter, C., Pouton, C., Johnston, A., Yeo, L. Y., Cavalieri, F., Yarovsky, I., Kent, S., Cortez-Jugo, C., O'Brien-Simpson, N. M., Hinde, E., Yeo, L. Y. & Wise, A.
25/06/20 → 24/06/21
Project: Research
-
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology
Davis, T., Boyd, B., Bunnett, N., Porter, C., Caruso, F., Kent, S., Thordarson, P., Kearnes, M., Gooding, J., Kavallaris, M., Thurecht, K., Whittaker, A. K., Parton, R., Corrie, S. R., Johnston, A., McGhee, J., Greguric, I. D., Stevens, M. M., Lewis, J., Lee, D. S., Alexander, C., Dawson, K., Hawker, C., Haddleton, D., Thierry, B., Prestidge, C. A., Meyer, A., Jones-Jayasinghe, N., Voelcker, N. H., Nann, T. & McLean, K.
Australian Research Council (ARC), Monash University, University of Melbourne, University of New South Wales (UNSW), University of Queensland , University of South Australia, Monash University – Internal Faculty Contribution, University of Wisconsin Madison, Memorial Sloan Kettering Cancer Center, University of California System, University College Dublin, Imperial College London, University of Warwick, SungKyunKwan University, Australian Nuclear Science and Technology Organisation (ANSTO) , University of Nottingham
30/06/14 → 29/06/21
Project: Research
-
MicruCubes as Vaccines for the Developing World
Coulibaly, F., Ffrench, R., Kent, S., Lightowlers, M. & Purcell, D. F. J.
Bill and Melinda Gates Foundation, Monash University – Internal University Contribution, Burnet Institute (Australia)
6/03/13 → 31/03/15
Project: Research
-
Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2(Front. Immunol., (2022), 13, (889372), 10.3389/fimmu.2022.889372)
Wines, B. D., Kurtovic, L., Trist, H. M., Esparon, S., Lopez, E., Chappin, K., Chan, L. J., Mordant, F. L., Lee, W. S., Gherardin, N. A., Patel, S. K., Hartley, G. E., Pymm, P., Cooney, J. P., Beeson, J. G., Godfrey, D. I., Burrell, L. M., van Zelm, M. C., Wheatley, A. K., Chung, A. W., & 4 others, 10 Jan 2023, In: Frontiers in Immunology. 13, 2 p., 1122516.Research output: Contribution to journal › Comment / Debate › Other › peer-review
Open Access -
Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines
Ju, Y., Carreño, J. M., Simon, V., Dawson, K., Krammer, F. & Kent, S. J., Mar 2023, In: Nature Reviews Immunology. 23, 3, p. 135-136 2 p.Research output: Contribution to journal › Comment / Debate › Other › peer-review
Open Access3 Citations (Scopus) -
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine
Ju, Y., Lee, W. S., Pilkington, E. H., Kelly, H. G., Li, S., Selva, K. J., Wragg, K. M., Subbarao, K., Nguyen, T. H. O., Rowntree, L. C., Allen, L. F., Bond, K., Williamson, D. A., Truong, N. P., Plebanski, M., Kedzierska, K., Mahanty, S., Chung, A. W., Caruso, F., Wheatley, A. K., & 2 others, 23 Aug 2022, In: ACS Nano. 16, 8, p. 11769-11780 12 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access31 Citations (Scopus) -
A Quantitative Approach to Unravel the Role of Host Genetics in IgG-FcγR Complex Formation After Vaccination
Lemke, M. M., Theisen, R. M., Bozich, E. R., McLean, M. R., Lee, C. Y., Lopez, E., Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kratochvil, S., Wines, B. D., Hogarth, P. M., Kent, S. J., Chung, A. W. & Arnold, K. B., 22 Feb 2022, In: Frontiers in Immunology. 13, 16 p., 820148.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Cutting Edge: SARS-CoV-2 Infection Induces Robust Germinal Center Activity in the Human Tonsil
Tan, H. X., Wragg, K. M., Kelly, H. G., Esterbauer, R., Dixon, B. J., Lau, J. S. Y., Flanagan, K. L., van de Sandt, C. E., Kedzierska, K., McMahon, J. H., Wheatley, A. K., Juno, J. A. & Kent, S. J., 15 May 2022, In: Journal of Immunology. 208, 10, p. 2267-2271 5 p.Research output: Contribution to journal › Article › Research › peer-review
4 Citations (Scopus)